HEPATOMA

Clinical trials for HEPATOMA explained in plain language.

Never miss a new study

Get alerted when new HEPATOMA trials appear

Sign up with your email to follow new studies for HEPATOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

New combo therapy shows promise for Tough-to-Treat liver cancer

Disease control Completed

This study tested a combination of two immunotherapy drugs, relatlimab and nivolumab, in 266 adults with advanced liver cancer who had not received immunotherapy before but had already tried other treatments. The goal was to see if the combination could shrink tumors and control …

Matched conditions: HEPATOMA

Phase: PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control

Last updated May 17, 2026 05:33 UTC

HEPATOMA

Get alerted when new HEPATOMA trials appear

New combo therapy shows promise for Tough-to-Treat liver cancer